Buy the British Pharmacopoeia 2027

Purchase the latest BP 2027 edition to ensure you are fully prepared for any new or changed standards becoming legally effective on 1 January 2027.

Select the format that works best for you, whether it's a multi-user licence for shared online access, a single-user licence for individual use, or download and print options.

All texts from the Ph. Eur. up to Issue 14.1 will be included as in-year online and download updates.


Why the BP?

The British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes approximately 4,000 monographs, which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and internationally.

New in the BP 2027 edition

The BP 2027 editions deliver enhanced functionality to support efficient identification and review of legislative updates. A new Advanced Search filter allows users to refine results by new or updated text, while clear status flags within search results indicate whether content is new or revised in the 2027 edition.

Additionally, we have made available to all users an omitted text list since the 2014 edition, complete with the year of last inclusion and direct links, ensuring continuity and greater transparency when tracking regulatory changes.

New monographs and British Pharmacopoeia Chemical reference substances (BPCRS):

  • 18 new BP monographs and all the new and updated texts featured in Issues 12.1 to 13.1 of the European Pharmacopoeia**
  • One new infrared reference spectrum has been added to the collection
  • 13 references to new BPCRS
  • 132 amended BP texts
  • All texts from the Ph. Eur. up to Issue 14.1 are included as in-year online and download updates



Individual formats

BP 2027, BP Archive and BAN Online - £1,300

Single-user access to the BP 2027 online for one named person. With this licence, you gain access to the BP Archive and British Approved Names (BAN). The archive includes all editions since BP 2014. Access expires on 31 March 2028.*

QTY (Max 10)    

BP 2027 and BP Archive Online - £1,150

Single-user access to the BP 2027 online for one named person. With this licence, you gain access to the BP Archive, which includes all editions since BP 2014. Access expires on 31 March 2028.*

QTY (Max 10)    

BP 2027 and BAN Online - £1,100

Single-user access to the BP 2027 online for one named person. With this licence, you gain access to the British Approved Names (BAN). Access expires on 31 March 2028.*

QTY (Max 10)    

BP 2027 Online - £950

Single-user access to the BP 2027 online for one named user. Access expires on 31 March 2028.*

QTY (Max 10)    

BP 2027 Six-volume print set - £1,200

Six-volume print set, which includes the BP veterinary.**

BP 2027 Download - £1,000

Single-user download for offline access.*

*Read important information about these products and their limits before purchasing.

** The BP 2027 print edition includes European Pharmacopoeia content up to Issue 12.3. Requirements published in Issue 13.1 are available only in the BP 2027 Online and Download editions at publication.


If you have any questions about purchasing the BP, you can contact our sales enquiry team from Monday - Friday 08.00 to 18.00 GMT.

e: pharmahealth@tso.co.uk

t: +44 (0) 333 0917 023

a: The Stationery Office Ltd (TSO), PO box 29, Norwich, NR3 1GN

Alternatively, you can speak to an advisor via our

Webchat